Czech National Bank boosted its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 7.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 138,383 shares of the real estate investment trust’s stock after buying an additional 9,028 shares during the quarter. Czech National Bank’s holdings in Ventas were worth $12,288,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. NewEdge Advisors LLC grew its position in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after buying an additional 7,097 shares during the period. Empowered Funds LLC lifted its holdings in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the period. Woodline Partners LP lifted its holdings in Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the period. Focus Partners Wealth boosted its stake in Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Ventas in the second quarter valued at approximately $805,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Ventas
In related news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Get Our Latest Research Report on Ventas
Ventas Stock Up 1.1%
Ventas stock opened at $93.31 on Friday. The firm has a market capitalization of $47.87 billion, a price-to-earnings ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. The company’s 50 day simple moving average is $89.49 and its 200 day simple moving average is $86.10. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60.
Ventas Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is currently 385.19%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
